Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 227 entries
View as:

Docetaxel in Treating Patients With Stage IV Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003781 Org: User:
Start: 12/31/98 End: 06/30/03 Due: 06/30/04

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02099864 Org: User:
Start: 02/05/14 End: 07/08/24 Due: 07/08/25

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00242931 Org: User:
Start: 01/31/05 End: 03/31/08 Due: 03/31/09

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00074165 Org: User:
Start: 01/31/03 End: 12/31/10 Due: 12/31/11

Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET

Phase: N/A Priority: Normal
NCT ID: NCT05722925 Org: User:
Start: 10/04/23 End: 01/01/26 Due: 01/01/27

EXERCISING TOGETHER for Couples Coping With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03630354 Org: User:
Start: 01/18/19 End: 03/31/24 Due: 03/31/25

ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05368506 Org: User:
Start: 07/30/23 End: 07/31/25 Due: 07/31/26

Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02501759 Org: User:
Start: 05/31/15 End: 02/10/17 Due: 02/10/18

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Phase: N/A Priority: Normal
NCT ID: NCT05407168 Org: User:
Start: 10/31/22 End: 12/31/27 Due: 12/31/28

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT00397501 Org: User:
Start: 10/31/13 End: 10/31/13 Due: 10/31/14

Telehealth & HPV Self-Collection

Phase: N/A Priority: Normal
NCT ID: NCT05089825 Org: User:
Start: 01/19/22 End: 01/19/23 Due: 01/19/24

Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00017576 Org: User:
Start: 12/31/00 End: 07/31/06 Due: 07/31/07

Strength Training for Older Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00591747 Org: User:
Start: 11/30/05 End: 06/30/11 Due: 06/30/12

Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00238199 Org: User:
Start: 06/30/02 End: 08/31/06 Due: 08/31/07

Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00722072 Org: User:
Start: 07/31/08 End: 07/31/12 Due: 07/31/13

Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02359097 Org: User:
Start: 01/06/15 End: 03/12/21 Due: 03/12/22

Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01620216 Org: User:
Start: 05/11/12 End: 04/30/17 Due: 04/30/18

Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

Phase: N/A Priority: Normal
NCT ID: NCT00238355 Org: User:
Start: 08/31/03 End: 06/30/08 Due: 06/30/09

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00303849 Org: User:
Start: 09/15/05 End: 03/12/21 Due: 03/12/22

Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00227682 Org: User:
Start: 06/30/04 End: 02/28/06 Due: 02/28/07

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06630325 Org: User:
Start: 06/16/25 End: 06/30/33 Due: 06/30/34

Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00764517 Org: User:
Start: 08/31/08 End: 03/31/17 Due: 03/31/18

Pathogenesis of Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01728402 Org: User:
Start: 09/30/08 End: - Due: -

CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening

Phase: N/A Priority: Normal
NCT ID: NCT01773980 Org: User:
Start: 08/31/13 End: 04/30/15 Due: 04/30/16

Tissue Sample Collection From Patients With Fanconi Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00899522 Org: User:
Start: 08/31/05 End: 05/31/13 Due: 05/31/14